Modulating the Blood-Brain Barrier: A Comprehensive Review.

Area of Science:

• Neuroscience
• Pharmacology
• Drug Delivery

Background:

• The blood-brain barrier (BBB) severely limits therapeutic access to the central nervous system (CNS).
• Current CNS treatments primarily rely on small, lipophilic drugs due to BBB restrictions.
• Developing effective BBB modulators is essential for advancing CNS disease therapies.

Purpose of the Study:

• To review and compare diverse classes of blood-brain barrier (BBB) modulators developed over the past five decades.
• To analyze recent advancements, advantages, and disadvantages of various BBB modulation strategies.
• To provide insights into the future potential of BBB modulators in CNS drug development.

Main Methods:

• Comprehensive literature review of BBB modulators.
• Comparative analysis of different modulator classes based on efficacy, safety, and mechanism.
• Evaluation of historical trends and recent breakthroughs in BBB modulation.

Main Results:

• Identification of multiple classes of BBB modulators with varying mechanisms and efficacies.
• Summary of key advancements in BBB modulation technologies over the last 50 years.
• Assessment of the strengths and limitations associated with each modulator class.

Conclusions:

• Blood-brain barrier (BBB) modulation represents a critical area for CNS disease treatment innovation.
• Continued research and development of BBB modulators promise to expand therapeutic options for neurological disorders.
• The future of CNS drug development is intrinsically linked to the advancement of safe and effective BBB modulation strategies.